Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Bausch & Lomb
AddedFeb 13, 2024
UpdatedJun 28, 2026
Bausch & Lomb

Bausch & Lomb

Public

Bausch & Lomb: A global American firm specializing in the development and manufacturing of optical products.

HQ
Rochester, NY, US
Founded
1853
Overview
Compare
Fundraising
Employees
Website

Founded in 1853, Bausch & Lomb is a global American firm dedicated to improving vision and enhancing quality of life through innovative optical products. The company develops, manufactures, and markets a wide range of products including contact lenses, generic and prescription pharmaceuticals, intraocular lenses, and other eye surgery products for cataract and refractive surgery. Bausch & Lomb serves a diverse international market, focusing on providing high-quality eye care solutions to customers worldwide.

Notable figures associated with Bausch & Lomb include its founders John Jacob Bausch and Henry Lomb, who established the company's legacy of innovation and craftsmanship. The company has achieved significant milestones, such as pioneering advancements in contact lens technology and expanding its product portfolio to include cutting-edge surgical instruments. Bausch & Lomb's impact is evident in its longstanding reputation for quality and its commitment to helping millions of people see better to live better.

Bausch & Lomb - Quick Facts

When was Bausch & Lomb founded?

Bausch & Lomb was founded in 1853.

Where is Bausch & Lomb's headquarters located?

Bausch & Lomb's headquarters is located in Rochester, NY, US.

When was Bausch & Lomb's last funding round?

Bausch & Lomb's most recent funding round was for $1.4B (USD) in September 2023.

How much has Bausch & Lomb raised to-date?

As of Sep 11, 2023, Bausch & Lomb has raised a total of $1.4B (USD).

How many employees does Bausch & Lomb have?

Bausch & Lomb has 900 employees as of Feb 5, 2024.

Bausch & Lomb - Classification

Industry
  • Retail
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Manufacturing
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Eye Care
  • Pharmaceuticals
Tags
  • Healthtech
Unique IDs
  • secCik: 0001860742
  • ticker: BLCO
NAICS
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339115Ophthalmic Goods Manufacturing
  • 330000Manufacturing
  • 339000Miscellaneous Manufacturing
SIC
  • 3850Ophthalmic Goods
  • 3851Ophthalmic Goods
ISIC
  • 3250Manufacture of medical and dental instruments and supplies
Show 24 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 333300Commercial and Service Industry Machinery Manufacturing
  • 333310Commercial and Service Industry Machinery Manufacturing
  • 339113Surgical Appliance and Supplies Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 333000Machinery Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 3820Laboratory Apparatus And Analytical, Optical, Measuring, And Control
  • 3827Optical Instruments And Lenses
  • 2800Chemicals And Allied Products
  • 3900Miscellaneous Manufacturing Industries
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 8000Health Services
  • 2830Drugs
  • 5040Professional And Commercial Equipment And Supplies
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 5047Medical, Dental, And Hospital Equipment And Supplies
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified